Loader

Pathways

PathWhiz ID Pathway Meta Data

PW354583

Pw354583 View Pathway
metabolic

Xylose Degradation I

Escherichia coli O157:H7 str. EC4115
Escherichia coli can utilize D-xylose as the sole source of carbon and energy for the cell. A low-affinity proton motive force or a high-affinity ATP-driven (ABC) transport system brings unphosphorylated D-xylose into the cell. Following entry, D-xylose is converted to D-xylulose by an isomerase and then converted to the pentose phosphate pathway intermediate, D-xylulose 5-phosphate via a kinase. D-xylulose 5-phosphate can then enter pathways of metabolism to meet the cells needs.

PW337402

Pw337402 View Pathway
metabolic

Xylose Degradation I

Bacteroides stercoris ATCC 43183
Escherichia coli can utilize D-xylose as the sole source of carbon and energy for the cell. A low-affinity proton motive force or a high-affinity ATP-driven (ABC) transport system brings unphosphorylated D-xylose into the cell. Following entry, D-xylose is converted to D-xylulose by an isomerase and then converted to the pentose phosphate pathway intermediate, D-xylulose 5-phosphate via a kinase. D-xylulose 5-phosphate can then enter pathways of metabolism to meet the cells needs.

PW146148

Pw146148 View Pathway
drug action

Xylose Drug Metabolism Action Pathway

Homo sapiens

PW123873

Pw123873 View Pathway
signaling

yap taz

Mus musculus

PW145407

Pw145407 View Pathway
drug action

Yohimbine Drug Metabolism Action Pathway

Homo sapiens

PW176298

Pw176298 View Pathway
metabolic

Yohimbine Predicted Metabolism Pathway

Homo sapiens
Metabolites of Yohimbine are predicted with biotransformer.

PW146580

Pw146580 View Pathway
drug action

Yttrium Y-90 Drug Metabolism Action Pathway

Homo sapiens

PW144666

Pw144666 View Pathway
drug action

Zafirlukast Drug Metabolism Action Pathway

Homo sapiens

PW176359

Pw176359 View Pathway
metabolic

Zafirlukast Predicted Metabolism Pathway

Homo sapiens
Metabolites of sildenafil are predicted with biotransformer.

PW000723

Pw000723 View Pathway
drug action

Zalcitabine Action Pathway

Homo sapiens
Zalcitabine (ddc) is a dideoxynucleoside antiretroviral drug that when used in combination with zidovudine improves the viral load and CD4+ cell count of patients infected with Human Immunodeficiency Virus Type 1 (HIV-1). Zalcitabine is phosphorylated to it’s active form metabolite 2′,3′-dideoxycytidine 5′-triphosphate (ddCTP) in both healthy and infected cells. ddCTP competes with deoxycytidine triphosphate inhibiting the enzyme reverse transcriptase from using the substrates to elongate the viral DNA strand ultimately halting HIV replication.